Schaeffer's Outside the Box Blog
Stocks quoted in this article:

I juggle cats for a living; today I'm adding chainsaws and bowling balls to the mix as we're T-1 until Festivus!

We still have some room -- not much, but some -- so if you wanna celebrate the journey, help some kids, and network with the finest human capital in the financial universe, please visit www.rpfoundation.org to lock your spot.

Tape-wise? Oh yeah, that! I rounded up on my S&P February out-of-the-money puts this morning, with the final addition precisely where I bought -- and sold -- them earlier this week (my average cost is about a nickel higher).

I'm not sure if this is a speculative bet or a hedge; prolly a little bit of both. While I've taken the lion's share of my trading capital off the table into year-end (literally), I left some house money to see if I can turn it into money that will help pay for a house.

My longs? Cannabis plays, which I can't mention by name because 1) they're too thin and 2) they're literally lottery tickets as Altria (NYSE:MO) or Archer Daniels (NYSE:ADM) will likely bogart the space by the time the smoke clears rises.

The net sum of those common stock positions is greater than the February downside premium I own so I'm technically long delta with positive gamma, but in reality, I own a thesis against the tape. In other words, I'm long weed and short speed for reasons already mentioned (higher tax revenue, more jobs, less crime, and no coverage (yet) on Wall Street).

In terms of trading tells, Apple (NASDAQ:AAPL) is an obvious focus ($500—recent lows—is the level that must hold, if and when) although the tape did a nifty job of proving Newton wrong yesterday. Breadth is 3:2 negative (not yet a tell) and the banks -- which held the market up yesterday -- are mixed. BKX 47 is the level of lore in that arena.

What else? If you missed yesterday's conversation with Jeff Saut, you should give it a read; he's as good as it gets and he speaks to specific stocks he likes -- American Tower (NYSE:AMT), SBA Communications (NASDAQ:SBAC), DaVita (NYSE:DVA), and DexCom (NASDAQ:DXCM) -- and sectors he's avoiding (consumer non-durables).

And yes, he'll be at Festivus, along with other "fan favorites" such as Peter Prudden, Michael Gayed, Barry Ritholtz, Peter Atwater, Mark Dow, Aaron Brown, Stephanie Pomboy, Ivan Zinn, Scott Redler, and Lloyd Khaner. Not that I'm a namedropper...

A'ight, lemme get this to you as I've got an Abyssinian spinning through the air.

Hey Crash, watch that chainsaw!

R.P.

This article by Todd Harrison originally published on Minyanville.

Below, find some more great content from Minyanville:

Twitter: @minyanville

Disclaimer: The views represented on this blog are those of the individual authors only, and do not necessarily represent the views of Schaeffer's Investment Research.


permanent link
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Partner Center

© 2014 Schaeffer's Investment Research, Inc. 5151 Pfeiffer Road, Suite 250, Cincinnati, Ohio 45242 Phone: (800) 448-2080 FAX: (513) 589-3810 Int'l Callers: (513) 589-3800 Email: service@sir-inc.com

All Rights Reserved. Unauthorized reproduction of any SIR publication is strictly prohibited.

Market Data provided by QuoteMedia.com | Data delayed 15-20 minutes unless otherwise indicated.